Biomolecular interaction and cytotoxicity of ruthenium(III) benzothiazole substituted ferrocenyl thiosemicarbazone complexes  by Sampath, K. & Jayabalakrishnan, C.
Arabian Journal of Chemistry (2014) xxx, xxx–xxxKing Saud University
Arabian Journal of Chemistry
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEBiomolecular interaction and cytotoxicity
of ruthenium(III) benzothiazole substituted
ferrocenyl thiosemicarbazone complexesK. Sampath a, C. Jayabalakrishnan b,*a Department of Chemistry, Kumaraguru College of Technology, Coimbatore 641049, Tamil Nadu, India
b Post-Graduate and Research Department of Chemistry, Sri Ramakrishna Mission Vidyalaya College of Arts
and Science, Coimbatore 641020, Tamil Nadu, IndiaReceived 30 July 2012; accepted 20 December 2013*
E
Pe
18
ht
P
oKEYWORDS
Ruthenium(III) complexes;
Benzothiazolyl
thiosemicarbazide;
DNA binding;
DNA cleavage;
CytotoxicityCorresponding author. Tel.
-mail address: drcjbstar@gm
er review under responsibilit
Production an
78-5352 ª 2013 King Saud U
tp://dx.doi.org/10.1016/j.arab
lease cite this article in press as:
cenyl thiosemicarbazone comple: +91 42
ail.com
y of King
d hostin
niversity
jc.2013.1
Sampath,
xes. ArabiAbstract In our search for new anticancer and DNA interacting agents, ruthenium(III) thiosem-
icarbazone complexes of the type [RuCl2(EPh3)L] (where E = P/As; L = monobasic tridentate thi-
osemicarbazone ligand) were synthesized and characterized by physico-chemical and spectroscopic
methods. All the ligands and complexes exhibit noticeable growth inhibition against fungal species
and bacterial species. The interactions of these complexes with biomolecule, CT-DNA were inves-
tigated by absorbance measurement and gel electrophoresis. Absorption spectral study indicates
that the ruthenium(III) complexes have an intrinsic binding constant in the range of 1.0–
3.6 · 104 M1. The complexes exhibit a remarkable DNA cleavage activity with CT-DNA in the
presence of hydroxyl radical. The cleavage activity was carried out with the variation of the concen-
tration of complexes and incubation time. Further, an in vitro cytotoxicity study of the complexes
exhibited antitumor activity against the HeLa tumor cell line. This research may provide valuable
insight into the interactions of metal complexes with DNA and cytotoxicity, knowledge that is an
excellent back drop for the rational design of promising drugs.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.2 2692461.
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In the recent years the bioorganometallic chemistry of ferrocene
has aroused a great interest and its study has been encouraged
by its potential biological applications (Gimeno et al., 2011).
The ferrocenyl group has been incorporated into the structure
of a number of biologically active molecules such as antibiotic
(Edwards et al., 1976), anticancer (Jaouen et al., 2004) or malar-
ia drugs (Biot et al., 2005) resulting in an increase of the activity
and these compounds can be used for synthesis of a wide num-
ber of pharmacologically active compounds (Azza and Hussen,ier B.V. All rights reserved.
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2 K. Sampath, C. Jayabalakrishnan2009). Ferrocene containing complexes can be regarded asmulti
nuclear molecules possessing the features of both organometal-
lic and coordination complexes (Jeragh and Dissouky, 2005).
Many transitionmetal complexes of ferrocene derived thiosemi-
carbazones have been found to be active against pesticides and
fungicides (Singh et al., 2002). A complex of thiosemicarba-
zones has also been screened for medicinal properties, shown
to possess some degree of cytotoxic activity (Prabhakaran
et al., 2011). It is well known that several metal ions enhance
and modify the biological activities of thiosemicarbazones;
much attention on the ruthenium atom has been drawn toward
the chemistry of ruthenium (Sharma et al., 2007). Ruthenium
complexes were used as antitumor agents with selective antimet-
astatic properties and low systemic toxicity (Trynda-Lemiesz,
2004). Apart from this, ruthenium complexes appear to pene-
trate reasonably well into the tumor cells and bind effectively
to DNA (Chitrapriya et al., 2008) because DNA is generally
the primary intracellular target of anticancer drugs. So, the
interaction of these drugs with DNA can cause DNA damage
in cancer cells and result in cell death (Collinson and Fenton,
1996; Hecht, 2000). In particular, benzothiazolyl thiosemicar-
bazones represent a very interesting class of compounds because
of their wide applications in pharmaceutical aspects such as
antibacterial and antifungal (Pandeya et al., 1999). Based on
the various activities of these compounds, we have focused on
the construction and biological investigation of a novel ruthe-
nium(III) complexes containing benzothiazole substituted ferr-
ocenyl thiosemicarbazones. This paper presents the synthesis,
characterization, DNA binding, DNA cleavage and anticancer
activity of mixed ligand ruthenium(III) complexes.H
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Scheme 1 Outline synthesis of the thiosemicarbazone ligands.2. Experimental
2.1. Materials and methods
All the chemicals used were chemically pure and AR grade. Sol-
vents were puriﬁed and dried according to the standard proce-
dure (Vogel, 1989). RuCl3Æ3H2O was purchased from Loba
Chemie and was used without further puriﬁcation. Calf-thymus
(CT-DNA) was purchased from Bangalore Genei, Bangalore,
India. The Human Cervical cancer cell line HeLa was obtained
from National centre for cell science (NCCS), Pune, India. The
carbon, hydrogen, nitrogen and sulfur analyses were performed
on a Vario EL III CHNS analyser at STIC, Cochin University
of Science and Technology, Kerala, India. IR spectra were re-
corded as KBr pellets in the 400–4000 cm1 region using Perkin
Elmer FTIR 8000 spectrophotometer. Electronic spectra were
recorded in dimethyl sulphoxide solution with a Systronics
double beam UV–vis spectrophotometer 2202 in the range
200–800 nm. Magnetic susceptibility measurements of the
complexes were recorded using Guoy balance. EPR spectra
were recorded on a varian E-112 ESR spectrophotometer at
X-band microwave frequencies for powdered samples at room
temperature and liquid nitrogen temperature at the Indian
Institute of Technology, Bombay, Mumbai. Anti cancer studies
were carried out at the Kovai Medical Centre and Hospital
Pharmacy College, Coimbatore, Tamil Nadu. Melting points
were recorded on a Veego VMP-DS model heating table and
were not corrected. The thiosemicarbazone ligands (Sampath
and Jayabalakrishnan, 2013) and the metal precursors
[RuCl3(PPh3)3] (Chatt et al., 1968) and [RuCl3(AsPh3)3]Please cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
ocenyl thiosemicarbazone complexes. Arabian Journal of Chemistry (2014), http:/(Thangadurai and Natarajan, 2001) were prepared according
to the reported procedures.
2.2. Synthesis of thiosemicarbazone ligands
A solution of 6-nitro/H-2-benzothiazolyl thiosemicarbazide
(2.24–2.69 g, 10 mmol) in methanol (20 mL) was added to a
solution of ferrocene carboxaldehyde/acetyl ferrocene (2.14–
2.28 g, 10 mmol) in methanol (20 mL) along with a few drops
of glacial acetic acid. The mixture was reﬂuxed for 8 h. The
resultant product was washed with methanol and the purity
of the ligands was checked by TLC. The outline synthesis of
thiosemicarbazone ligands is shown in Scheme 1.
2.3. Synthesis of ruthenium(III) thiosemicarbazone complexes
All the reactions were carried out under strictly anhydrous con-
dition. The monobasic tridentate thiosemicarbazones (0.042–
0.048 g, 0.1 mmol) were added to a solution of [RuCl3(EPh3)3],
(E = P/As) (0.090–0.113 g) in 1:1 M ratio in benzene-methanol/
tetrahydrofuran (50 mL)mixture, and then reﬂuxed for 7 h. The
resulting solutionwas concentrated to about 3 cm3 and the com-
plexes were precipitated by the addition of a small quantity of
petroleum ether (60–80 C). The complexes were then ﬁltered
off, washed with petroleum ether and recrystallized from tetra-
hydrofuran/CH2Cl2/petroleum ether and dried under vacuo.
2.4. Antimicrobial assay
The agar diffusion method was followed for antibacterial and
antifungal susceptibility tests. Petri plates were prepared by
pouring 10 mL of Mueller Hinton Agar for bacteria and al-
lowed to solidify. These agar plates were inoculated withinteraction and cytotoxicity of ruthenium(III) benzothiazole substituted ferr-
/dx.doi.org/10.1016/j.arabjc.2013.12.017
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cells mL1) and uniformly spread. A 6 mm well was cut at
the center of the agar plate and the well was ﬁlled with the
solution of the complexes. The diameter of the inhibition zone
observed around the well was measured for each bacterium
after 24 h of incubation at 37 C. One well was ﬁlled with ster-
ile distilled water to serve as a control. For fungus, Sabouraud
Dextrose Agar medium was amended with the complexes when
the medium was warm, and poured into petri plates. After
solidiﬁcation of the medium, mycelia disks (6 mm diameter)
of the test fungi were inoculated at the center of the plates.
The diameter of the inhibition zone for each fungus was mea-
sured after 48 h of incubation at 28 C.
2.5. DNA-binding and cleavage assay
2.5.1. Electronic absorption spectroscopy
All the experiments involving the binding of ruthenium(III)
complexes with CT-DNA were carried out in a double distilled
water buffer with tris(hydroxymethyl)-aminomethane (Tris,
5 mM) and sodium chloride (50 mM) and adjusted to pH 7.2
with hydrochloric acid. A solution of CT-DNA in the buffer
gave a ratio of UV absorbance of about 1.9 at 260 and
280 nm, indicating that the DNA was sufﬁciently free of pro-
tein. The compounds were dissolved in a mixed solvent of
5% DMSO and 95% Tris–HCl buffer. Absorption titration
experiments were performed with ﬁxed concentrations of the
compounds (20 lM) with varying concentration of DNA
(0–40 lM). While measuring the absorption spectra, an equal
amount of DNA was added to both the test solution and the
reference solution to eliminate the absorbance of DNA itself.
The values of the intrinsic binding constants Kb were calculated
by regression analysis using the equation (Wolfe et al., 1987).
½DNA=ðea  efÞ ¼ ½DNA=ðeb  efÞ þ 1=Kbðea  efÞ
where [DNA] is the concentration of CT-DNA in base pairs
and ea, ef and eb are extinction coefﬁcients of the apparent, free
and bound metal complex, respectively and Kb is the equilib-
rium binding constant in M1. In the plots of [DNA]/(eaef)
versus [DNA], Kb is given by the ratio of slope to the intercept.
2.5.2. DNA cleavage
The DNA cleavage activity of the ruthenium(III) complexes
was monitored by agarose gel electrophoresis on CT DNA.
The tests were performed under aerobic condition with H2O2
as an oxidant. Each reaction mixture contained 30 lM of CT
DNA, 30 and 60 lM of each complex in DMSO and 60 lM
of hydrogen peroxide in 50 mM Tris–HCl, (pH 7.1). The reac-
tion mixture was incubated for 2 h and 4 h at 37 C. After
incubation, 1lL of loading buffer (0.25% bromophenol blue,
0.25% xylene cynol and 60% glycerol) was added to the reac-
tion mixture and loaded onto a 1% agarose gel containing
1.0 lg/mL of ethidium bromide. The electrophoresis was car-
ried out in Tris–acetic acid EDTA buffer at 50 V. The bands
were visualized under UV light and photographed.
2.6. Cytotoxicity assay
The human cervical cancer cell line (HeLa) was obtained from
the National Centre for Cell Science (NCCS), Pune, and grownPlease cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
ocenyl thiosemicarbazone complexes. Arabian Journal of Chemistry (2014), http:/in Eagles Minimum Essential Medium containing 10% fetal
bovine serum (FBS). All cells were maintained at 37 C, 5%
CO2, 95% air and 100% relative humidity. Maintenance cul-
tures were passaged weekly, and the culture medium was chan-
ged twice a week.
The monolayer cells were detached with trypsin–ethylene-
diaminetetraacetic acid (EDTA) to make single cell suspen-
sions and viable cells were counted using a hemocytometer
and diluted with medium with 5% FBS to give a ﬁnal density
of 1 · 105 cells/mL. One hundred microliters per well of cell
suspension were seeded into 96-well plates at a plating density
of 10,000 cells/well and incubated to allow for cell attachment
at 37 C, 5% CO2, 95% air and 100% relative humidity.
After 24 h the cells were treated with serial concentrations
of the extracts and fractions. They were initially dissolved in
neat DMSO and further diluted in serum free medium to
produce various concentrations. One hundred microliters
per well of each concentration was added to plates to obtain
ﬁnal concentrations of 1.0, 0.5, 0.25, 0.125, and 0.063 lg/mL.
The ﬁnal volume in each well was 200 lL and the plates were
incubated at 37 C, 5% CO2, 95% air and 100% relative
humidity for 48 h. The medium containing without samples
were used as control. Triplicate runs were carried out for all
concentrations.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) is a yellow water soluble tetrazolium salt. A mito-
chondrial enzyme in living cells, succinate-dehydrogenase,
cleaves the tetrazolium ring, converting the MTT to an insol-
uble purple formazan. Therefore, the amount of formazan pro-
duced is directly proportional to the number of viable cells.
After 48 h of incubation, 15 lL of MTT (5 mg/mL) in phos-
phate buffered saline (PBS) was added to each well and incu-
bated at 37 C for 4 h. The medium with MTT was then
ﬂicked off and the formed formazan crystals were solubilized
in 100 lL of DMSO and then the absorbance at 570 nm was
measured using a micro plate reader. The% cell inhibition
was determined using the following formula.
%Growth Inhibition ¼ 100AbsðsampleÞ=AbsðcontrolÞ
 100:
Nonlinear regression graph was plotted between % Cell inhibi-
tion and Log10 concentration and IC50 was determined using
GraphPad Prism software (Monks et al., 1991).
3. Results and discussion
A new series of ruthenium(III) thiosemicarbazone complexes
of the type [RuCl2(EPh3)L] (E = P/As; L = monobasic tri-
dentate thiosemicarbazone ligands) were achieved by reacting
ruthenium(III) precursors [RuCl3(EPh3)3] with monobasic
tridentate thiosemicarbazone ligands in 1:1 M ratio,
respectively in benzene-methanol/tetrahydrofuran mixture
(Scheme 2).
The synthesized ruthenium(III) thiosemicarbazone com-
plexes are stable in air at room temperature, non-hygroscopic
in nature and soluble in common solvents such as dichloro-
methane, dimethyl formamide, dimethyl sulphoxide, etc. The
analytical data of the complexes are in good agreement with
the calculated values thus conﬁrming the proposed hetero
bimetallic composition for all the complexes (Table 1).interaction and cytotoxicity of ruthenium(III) benzothiazole substituted ferr-
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Scheme 2 Formation of ruthenium(III) thiosemicarbazone
complexes.
4 K. Sampath, C. Jayabalakrishnan3.1. IR spectroscopy
The important IR absorption frequencies of the synthesized
complexes are shown in Table 2. The free ligands display
m(C‚S) absorptions in the region 804–826 cm
1, shifts to 723–
746 cm1 in the spectra of the complexes. This observation
may be attributed to the enolization of ANHAC‚S and sub-
sequent coordination through deprotonated sulfur (Mahalin-
gam et al., 2010). The ligands showed a strong band in the
range 1632–1642 cm1 which is characteristic of the azome-
thine group m(C‚N). Coordination of the thiosemicarbazone
to the ruthenium atom through the azomethine nitrogen atom
is expected to reduce the electron density in the azomethine
link and thus lowers the m(C‚N) absorption frequency in the re-
gion 1610–1639 cm1 (Bechford et al., 2009). IR spectrum of
the ligands revealed a medium intensity band in the region
1514–1593 cm1 m(C‚N) of the thiazole ring, which is shifted
to lower frequency in the range 1457–1557 cm1 after com-
plexation, which also indicates that it has been affected upon
coordination to the metal ions (Prasad et al., 2010). The
m(CASAC) at 616–618 cm
1 of the thiazole ring remains un-
changed which demonstrated that the thiazole group of sulfur
does not coordinate to the ruthenium metal (Alam et al.,Table 1 Analytical data of ruthenium(III) thiosemicarbazone comp
Complexes Color Mol. mass Decomposition tempera
[RuCl2(PPh3)L
1] Black 867 >300
[RuCl2(AsPh3) L
1] Brown 911 >300
[RuCl2(PPh3) L
2] Brown 853 >300
[RuCl2(AsPh3) L
2] Black 897 >300
[RuCl2(PPh3) L
3] Black 912 >300
[RuCl2(AsPh3) L
3] Black 956 >300
[RuCl2(PPh3) L
4] Brown 898 >300
[RuCl2(AsPh3) L
4] Brown 942 >300
Please cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
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the spectra of the complexes are attributed to the m(RuAN)
and m(RuAS) vibrations (Manivannan et al., 2007). The band
at 486–491 cm1 was assigned to the m(FeACp) stretching fre-
quency (Abd-Elzaher and Ali, 2006). In addition, other char-
acteristic bands due to triphenylphosphine/triphenylarsine
are also present in the expected region.
3.2. Electronic spectra
The electronic absorption spectra of the free ligands and their
complexes were recorded in DMSO and the UV–vis data were
listed in Table 2. The ground state of ruthenium(III) is
2T2g and ﬁrst existed doublet levels in the order of increasing
energy are 2A2g and
2A1g, which arise from t
4
2g e
1
g conﬁguration
(Venkatachalam et al., 2008). The spectra of the free ligands
showed the two type of transitions appearing in the range
298–305 and 368 nm are due to p–p* and n–p* transitions
involving molecular orbital of the cyclopentadienyl ring,
C‚N and enolic –SH chromophore. The shoulder in the re-
gion 430–447 nm is attributed to the transition of 3d electron
on iron to either non-bonding or antibonding orbitals of the
cyclopentadienyl ring (Prabhakaran et al., 2011). These bands
were shifted in the spectra of the complexes. The
ruthenium(III) complexes in the visible region display a strong
band in the range 394–416 nm that is assigned to be the LMCT
transitions (Muthukumar et al., 2010a,b). In a d5 system, espe-
cially in ruthenium(III) which has relatively high oxidizing
properties, the charge transfer bands of the type Lpyﬁ T2g
are prominent in the low energy region, which obscures the
weaker bands due to d–d transitions. The absorption between
440–480 nm is attributed to MLCT from Fe to either the non-
bonding or antibonding orbitals of the cyclopentadienyl ring
(Prabhakaran et al., 2011). The lower wavelength bands are char-
acterized as ligand centered transitions occurring within the
ligand orbitals. The patterns of the electronic spectra of all the
complexes indicate the presence of an octahedral environment
around the ruthenium atom (Muthukumar et al., 2010a,b).
3.3. Magnetic moment
The magnetic moment for all the complexes has been measured
at room temperature using the Guoy balance. The values ob-
tained in the range 1.62–1.69 BM indicates the presence of
one unpaired electron, suggesting a low spin t52g conﬁguration
for all the ruthenium(III) atoms in octahedral environment
(Muthukumar et al., 2010a,b).lexes.
ture (C) Calculated (found) (%)
C H N S
52.60(52.32) 3.72(3.57) 6.46(6.23) 7.39(7.42)
50.07(50.27) 3.54(3.72) 6.15(6.10) 7.03(7.78)
52.06(52.47) 3.54(3.49) 6.56(6.46) 7.51(7.21)
49.51(49.18) 3.37(3.76) 6.24(6.83) 7.15(7.46)
50.01(50.62) 3.42(3.73) 7.67(7.23) 7.03(7.64)
47.71(47.18) 3.27(3.75) 7.32(7.69) 6.70(6.13)
49.46(49.28) 3.25(3.31) 7.79(7.42) 7.14(7.64)
47.15(47.53) 3.10(3.78) 7.43(7.53) 6.80(6.19)
interaction and cytotoxicity of ruthenium(III) benzothiazole substituted ferr-
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Table 2 IR and electronic data of ligands and ruthenium(III) thiosemicarbazone complexes.
Ligands and complexes FTIR (cm1) UV–vis (nm)
m(C‚N) m(C‚S) m(CAS) Thiazole m(RuAN) m(RuAS) m(FeACp)
m(C‚N) m(CAS)
aH L1 1642 804 – 1524 618 – – 487 298, 368, 447
aH L2 1633 820 – 1593 618 – – 488 305, 368, 447
aH L3 1632 821 – 1516 617 – – 489 300, 368, 430
aH L4 1635 826 – 1514 616 – – 486 305, 368, 437
[RuCl2(PPh3)L
1] 1635 – 723 1457 618 545 458 490 310, 368, 406, 476
[RuCl2(AsPh3) L
1] 1639 – 741 1472 617 474 457 489 308, 368, 411, 440
[RuCl2(PPh3) L
2] 1628 – 723 1557 617 540 457 487 305, 368, 394, 444
[RuCl2(AsPh3) L
2] 1616 – 742 1545 618 538 458 486 305, 368, 396, 476
[RuCl2(PPh3) L
3] 1628 – 745 1472 617 527 424 488 305, 368, 413, 480
[RuCl2(AsPh3) L
3] 1626 – 744 1478 617 537 457 491 308, 368, 413, 478
[RuCl2(PPh3) L
4] 1610 – 746 1461 617 540 426 490 308, 368, 416, 478
[RuCl2(AsPh3) L
4] 1612 – 744 1483 616 522 423 490 308, 368, 413, 480
a Reported value.
Biomolecular interaction and cytotoxicity of ruthenium(III) benzothiazole 53.4. EPR spectra
The room temperature and liquid nitrogen temperature EPR
spectra of powder samples were recorded at X-band frequen-
cies and the spectral data are given in Table 3. The EPR spec-
trum of the complex [RuCl2(AsPh3)L
1] recorded at room
temperature is shown in Fig. 1. [RuCl2(AsPh3)L
1] exhibits
three lines with different ‘g’ values gx = 2.53, gy = 2.57 and
gz = 2.21 indicating the presence of magnetic anisotropy.
The presence of three ‘g’ values is indicative of a rhombic dis-
tortion in this complex. Moreover the complexes, [RuCl2(-
AsPh3)L
2] and [RuCl2(PPh3)L
3] exhibit a characteristic of an
axially symmetric system with g^ around 2.42 and 2.82 and
gk around 1.89 and 2.31. For an octahedral ﬁeld with tetrago-
nal distortion gx = gy „ gz and hence two ‘g’ values indicate
tetragonal distortion in these complexes (Venkatachalam and
Ramesh, 2005). All other ruthenium(III) complexes exhibit a
single isotropic resonance with ‘g’ values in the range 2.55–
2.67, indicating very high symmetry around the ruthenium
atom; such isotopic lines are usually observed either due to
intermolecular spin exchange which can broaden the lines or
occupancy of the unpaired electrons in a degenerate orbital
(Raja and Ramesh, 2010). EPR spectra recorded for complexesTable 3 EPR spectral data of ruthenium(III) thiosemicarba-
zone complexes.
Complexes gx gy gz <g>
*
[RuCl2(PPh3)L
1] 2.57 2.57 2.57 2.57
[RuCl2(AsPh3) L
1] 2.53 2.57 2.21 2.43
[RuCl2(AsPh3) L
1] LNT 2.52 2.56 2.21 2.43
[RuCl2(PPh3)L
2] 2.67 2.67 2.67 2.67
[RuCl2(AsPh3) L
2] 2.42 2.42 1.89 2.24
[RuCl2(PPh3)L
3] 2.82 2.82 2.31 2.65
[RuCl2(PPh3)L
3] LNT 2.71 2.71 2.33 2.58
[RuCl2(AsPh3) L
3] 2.56 2.56 2.56 2.56
[RuCl2(PPh3)L
4] 2.62 2.62 2.62 2.62
[RuCl2(AsPh3) L
4] 2.55 2.55 2.55 2.55
LNT – spectra recorded at liquid nitrogen temperature.
* <g>= [1=3g2x þ 1=3g2y þ 1=3g2z ]1/2.
Please cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
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1] and [RuCl2(PPh3)L
3] at liquid nitrogen tem-
perature did not show much variation from the observed at
room temperature, indicating anisotropic resonance in this
complex. Furthermore, the position and nature of the lines
in the spectra of these complexes are similar to those of the
other octahedral ruthenium(III) complexes (Manimaran
et al., 2011; Raja and Ramesh, 2010).
3.5. Antimicrobial activity
The antimicrobial activities of the free ligands and the thio-
semicarbazone complexes were tested against the pathogenic
fungus (Aspergillus ochraceous, Paecilomyces variotii and
Botrytis Cineraia) and human pathogens (Escherichia coli,
Staphylococcus aureus and Klebsiella pneumonia). The screen-
ing data are reported in Table 4. Ruthenium chelates possess
higher antimicrobial activity than the respective free ligands.
The inhibition of fungal cells by ruthenium chelates is due to
the alteration in the cell permeability and subsequent injury
to the cell membrane (Raja et al., 2011; Leelavathy et al.,
2009). The inhibition activity of ruthenium chelates against
the bacteria suggesting that chelation facilitates the ability of
a complex to cross a cell membrane (Perez et al., 1990). Fur-
thermore, the mode of action of the compounds may involve
the hydrogen bond through >C‚N group with active centers
of all cell constituents resulting in interference with the normal
cell process (Arunachalam et al., 2010). The present system
possess better cytotoxicity than the other ruthenium complexes
(Manimaran et al., 2011). Even though the complexes possess
higher activity than the free ligands, they could not reach the
effectiveness of the standard drugs Cotrimazole and
Ciproﬂoxacine.
3.6. DNA-binding and cleavage assay
3.6.1. Electronic absorption spectroscopy
DNA-binding studies are important for the rational design
and construction of new and more efﬁcient drugs targeted to
DNA. Electronic absorption spectroscopy is one of the most
useful techniques for DNA-binding studies of metalinteraction and cytotoxicity of ruthenium(III) benzothiazole substituted ferr-
/dx.doi.org/10.1016/j.arabjc.2013.12.017
Figure 1 EPR spectrum of [RuCl2(AsPh3)L
1].
Table 4 Antimicrobial activity of ruthenium(III) thiosemicarbazone complexes.
Ligands and
complexes
Mean zone of inhibition (mm)a
Bacteria Fungi
E. coli Staphylococcus
aureus
Klebsiella
pneumoniae
Aspergillus
ochraceous
Pacilomyces
variotii
Botrytis
cineraia
H L1 14.7 15.2 15.1 14.5 13.3 15.6
H L2 11.4 10.4 13.1 13.6 12.7 13.3
H L3 13.7 14.8 11.9 15.9 13.6 15.8
H L4 10.6 10.6 12.6 11.9 12.3 12.6
[RuCl2(PPh3)L
1] 19.6 19.8 19.4 20.1 19.9 19.2
[RuCl2(AsPh3) L
1] 18.6 18.6 18.3 19.6 19.1 18.5
[RuCl2(PPh3) L
2] 17.4 17.1 17.8 19.1 16.9 –
[RuCl2(AsPh3) L
2] 16.5 16.5 16.5 18.5 – 16.2
[RuCl2(PPh3) L
3] 18.9 17.4 18.2 19.3 18.2 17.9
[RuCl2(AsPh3) L
3] 17.6 – 17.5 – 17.4 17.1
[RuCl2(PPh3) L
4] 17.1 16.9 17.2 17.2 16.5 16.4
[RuCl2(AsPh3) L
4] 16.5 15.8 16.4 16.7 15.7 15.9
Standards b 26 24 23 33 32 34
DMSO No activity
a Values are the mean diameter of inhibition zone (mm) and an average of triplicate runs.
b Standards: antibacterial studies – ciproﬂoxacine 5 lg/mL; antifungal studies – cotrimazole – 100 lg/mL. Ligands and Complexes concen-
tration were 150 lg/mL.
6 K. Sampath, C. Jayabalakrishnancomplexes. The spectral changes reﬂect the corresponding
changes in DNA in its conformation and structures after the
drug bound to DNA (Wang and Yang, 2005). Intercalative
mode of binding usually results in hypochromism and batho-
chromism due to strong stacking interaction between an aro-
matic chromophore and the base pairs of DNA. On the
other hand, metal complexes which non-intercalatively or elec-
trostatically bind with DNA may result in hyperchromism and
hypsochromism (Lawrence et al., 2006). The electronic spec-
trum of complexes, [RuCl2(PPh3)L
1], [RuCl2(AsPh3)L
2],
[RuCl2(PPh3)L
3] and [RuCl2(PPh3)L
4] in the presence and ab-
sence of DNA is shown in Fig. 2. The ruthenium(III) com-
plexes exhibit two bands in the region around 252–363 nm,
which is attributed to a p–p* intraligand transition. ThePlease cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
ocenyl thiosemicarbazone complexes. Arabian Journal of Chemistry (2014), http:/absorption spectra show clearly that the addition of DNA to
the complexes lead to strong hyperchromism accompanied
by the slight hypsochromism to the [DNA]/[Ru]. Obviously,
these spectral characteristics suggest that all the complexes
interact with DNA via electrostatically with the base pairs of
DNA. In order to evaluate quantitatively the DNA-binding
strength, the intrinsic DNA-binding constant, Kb of the ruthe-
nium(III) complexes has been estimated to be in the range
1.0 · 104 M1–3.6 · 104 M1 and is listed in the Table 5. This
is good agreement with the reported literatures (Liu et al.,
2005).
As the concentration of the DNA was increased, the
absorption intensity of [RuCl2(AsPh3)L
2] decreases initially
and on further increment, hyperchromism with slight blue shiftinteraction and cytotoxicity of ruthenium(III) benzothiazole substituted ferr-
/dx.doi.org/10.1016/j.arabjc.2013.12.017
[RuCl2(PPh3)L1]
[RuCl2(AsPh3)L2]
 [RuCl2(PPh3)L3]
 [RuCl2(PPh3)L4]
Figure 2 Absorption spectral traces of the complexes [RuCl2
(PPh3)L
1], [RuCl2(AsPh3)L
2], [RuCl2(PPh3)L
3] and [RuCl2(PPh3)
L4] with increasing concentration of CT-DNA in a Tris HCl–NaCl
buffer (pH 7.2).
Table 5 Absorption spectral properties of ruthenium(III)
complexes with DNA.
Complexes Kb · 104 M1
[RuCl2(PPh3)L
1] 1.0
[RuCl2(AsPh3) L
1] 1.6
[RuCl2(PPh3) L
2] 1.5
[RuCl2(AsPh3) L
2] a
[RuCl2(PPh3) L
3] 1.5
[RuCl2(AsPh3) L
3] 1.0
[RuCl2(PPh3) L
4] 3.6
[RuCl2(AsPh3) L
4] 1.4
aCould not be evaluated.
Biomolecular interaction and cytotoxicity of ruthenium(III) benzothiazole 7(5 nm) was observed. This behavior reveals an electrostatic
association of the complex with the helix surface (Chitrapriya
et al., 2010). Hyperchromicity and hypochromicity is the spec-
tral feature of DNA concerning its double helix structure.
Hyperchromic effect reﬂects the corresponding changes of
DNA in its conformation and structure after the complexesPlease cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
ocenyl thiosemicarbazone complexes. Arabian Journal of Chemistry (2014), http:/are bound to DNA. Hypochromism results from contraction
of DNA in the helix axis while hyperchromism results from
the damage of DNA helix structure. The binding constant of
the complex, [RuCl2(AsPh3)L
2] could not be evaluated due
to the random changes in the absorption on the addition of
DNA.
3.6.2. DNA cleavage activity
The metal complexes were able to cleave the DNA and the efﬁ-
ciency of the complexes compared with that of the control is
due to their efﬁcient DNA binding ability. The general oxida-
tive mechanisms proposed to account for DNA cleavage by
hydroxyl radicals via. abstraction of a hydrogen atom from su-
gar units and prediction of the release of speciﬁc residues aris-
ing from transformed sugars, depend on the position from
which the hydrogen atom is removed (Prativel et al., 1991).
In the present study, the CT-DNA gel electrophoresis exper-
iment was carried out for the complexes, [RuCl2(AsPh3)L
1],
[RuCl2(PPh3)L
2], [RuCl2(PPh3)L
3] and [RuCl2(PPh3)L
4]. The
complexes were selected for DNA cleavage activity because
these complexes exhibited higher binding afﬁnity in our DNA
binding study. The DNA cleaving ability of the complexes has
been investigated with various concentrations of the complexes
and at 2 h incubation time intervals in the presence of H2O2 as
an oxidant. Control experiment using DNA alone and DNA
with H2O2 (Lane 1 and 2) does not show any signiﬁcant cleav-
age of CT-DNA even on longer exposure time. From the Fig. 3,
it was found that, at very low concentration, few complexes ex-
hibit nuclease activity in the presence of H2O2. When the con-
centration increased to 60 lM for all the complexes, DNA
was completely damaged (Lane 3–10). This proves the catalytic
role of complexes in the oxidative cleavage (Reddy et al., 2011).
As can be seen from the Fig. 4, the amount of cleavage is
found to increase with increasing incubation time to 4 h, even
though the concentration of the complexes is 30 lM (Lane 3–
10). The amount of Form I diminished gradually, partly con-
verted to Form II and the intensity of the DNA decreased,
showing the potential chemical nuclease activity of the com-
plexes. Hence, we conclude that the ruthenium(III) complexes
cleaves DNA at different concentrations and at various incu-
bation time intervals in the presence of H2O2.
3.7. Cytotoxic activity evaluation
To test the cytotoxicity of ruthenium(III) complexes, [RuCl2
(AsPh3)L
1], [RuCl2(PPh3)L
2], [RuCl2(PPh3)L
3] and [RuCl2
(PPh3)L
4] human cervical cancer cell line (HeLa) was culturedinteraction and cytotoxicity of ruthenium(III) benzothiazole substituted ferr-
/dx.doi.org/10.1016/j.arabjc.2013.12.017
Figure 3 The gel electrophoresis showing the chemical nuclease
activity of CT-DNA incubated at 37 C for 2 h with different
concentration of complexes in the presence of H2O2 as an oxidant;
Lane 1: DNA alone; Lane 2: DNA+ 60 lM H2O2; Lane 3:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(AsPh3)L
1]; Lane 4:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(AsPh3)L
1]; Lane 5:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(PPh3)L
2]; Lane 6:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(PPh3)L
2]; Lane 7:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(PPh3)L
3]; Lane 8:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(PPh3)L
3]; Lane 9:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(PPh3)L
4]; Lane 10:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(PPh3)L
4].
Figure 4 The gel electrophoresis showing the chemical nuclease
activity of CT-DNA incubated at 37 C for 4 h with different
concentration of complexes in the presence of H2O2 as an oxidant;
Lane 1: DNA alone; Lane 2: DNA+ 60 lM H2O2; Lane 3:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(AsPh3)L
1]; Lane 4:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(AsPh3)L
1]; Lane 5:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(PPh3)L
2]; Lane 6:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(PPh3)L
2]; Lane 7:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(PPh3)L
3]; Lane 8:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(PPh3)L
3]; Lane 9:
DNA+ 60 lM H2O2 + 30 lM [RuCl2(PPh3)L
4]; Lane 10:
DNA+ 60 lM H2O2 + 60 lM [RuCl2(PPh3)L
4].
8 K. Sampath, C. Jayabalakrishnanin the presence of varying concentrations of complexes for
48 h. The inhibitory concentration 50 (IC50), is deﬁned as the
concentration required to reduce the size of the cell population
by 50%. The IC50 values are 178, 123, 149, 85 lM for com-
plexes [RuCl2(AsPh3)L
1], [RuCl2(PPh3)L
2], [RuCl2(PPh3)L
3]
and [RuCl2(PPh3)L
4] respectively against the HeLa cell line.
There are reports in the literature on the cytotoxic effects of
the complexes with longer incubation time periods (72 h).
The longer incubation period may result in the development
of cellular resistance for that particular complex (Ramachan-
dran et al., 2012). But, the data obtained for our complexes
showed signiﬁcant cytotoxicity with a short incubation period
(48 h). Hence, our ruthenium(III) complexes show signiﬁcant
activity against the tumor cell line. However, these values arePlease cite this article in press as: Sampath, K., Jayabalakrishnan, C. Biomolecular
ocenyl thiosemicarbazone complexes. Arabian Journal of Chemistry (2014), http:/lower than the standard anticancer drug cisplatin
(IC50 = 12.52 lM) (Krishnamorthy et al., 2011).4. Conclusion
The benzothiazole substituted ferrocenyl thiosemicarbazone
ruthenium(III) complexes were synthesized and characterized
by various physico-chemical and spectroscopic methods. The
complexes are tentatively assigned an octahedral geometry.
The inhibition activity against some plant pathogenic fungal
species and human pathogenic bacterial species of the thiosem-
icarbazone ligands exhibit good inhibition activity which is im-
proved by the presence of the ruthenium moiety. The DNA
binding study revealed that the complexes bind the DNA dou-
ble helix via electrostatic interaction. Intrinsic binding constant
of the complexes varies in the range of 1.0–3.6 · 104 M1.
From the intrinsic binding constant value, it is inferred that
the complexes containing electron donating group bind
strongly than the other complexes. On the other hand, the
complex [RuCl2(AsPh3)L
2] shows a dual mode of binding to
DNA. DNA cleavage studies revealed that the complexes have
the ability to cleave nucleic acids and the extent of the cleavage
is found to be dose and incubation time dependent. These
results should be valuable in understanding the mode of ruthe-
nium(III) complexes with DNA as well as laying a foundation
for the rational design of novel, powerful agents for probing
and targeting nucleic acids. Moreover, the cytotoxicity evalua-
tion in vitro shows that complexes displayed better antitumor
activity against the selected cell line, HeLa with a short incuba-
tion period.Acknowledgements
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